You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET tracer

Showing 1 - 25 of 5,066
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 6, 2023

Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)

Recruiting
  • Myocardial Fibrosis
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
May 11, 2023

Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)

Recruiting
  • Neurodegenerative Diseases
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 24, 2023

Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar)

Completed
  • Coronary Artery Disease
  • Ga-68 Galmydar
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 5, 2022

The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism

Recruiting
  • Parkinson Disease
  • Hefei, Anhui, China
    The First Affiliated Hospital of China University of Science and
Aug 17, 2023

Solid Tumor, Positron-Emission Tomography(PET) Trial in Suzhou ([68Ga]Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • [68Ga]Ga-NOTA-SNA002
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 3, 2022

PET Tracer Based FDG Signal for Predicting Prognosis in Acute

Enrolling by invitation
  • Acute Myeloid Leukemia
  • No intervention
  • Guangzhou, Guangdong, China
    First Affiliated Hospital of Jinan University
Jun 22, 2023

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's

Recruiting
  • Alzheimer Disease
  • Healthy
  • Positron Emission Tomography (PET) using two PET tracer under IND
  • Houston, Texas
    Houston Methodist Research Institute
Jan 20, 2023

Neuroendocrine Tumors, Prostate Cancer Trial in Salt Lake City (Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE

Recruiting
  • Neuroendocrine Tumors
  • Prostate Cancer
  • Single-Tracer FDG PET/CT Exam
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Dec 27, 2022

Healthy Subjects, Cardiovascular Disease Trial (18F-FDG, 11C-butanol)

Not yet recruiting
  • Healthy Subjects
  • Cardiovascular Disease
  • (no location specified)
Aug 22, 2023

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Using TSPO

Recruiting
  • Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
  • PET Tracer
  • +2 more
  • New York, New York
    NYU Langone Health
Nov 7, 2022

Alzheimer Trial in San Francisco ([18F]RP-115 PET/MRI)

Recruiting
  • Alzheimer Disease
  • [18F]RP-115 PET/MRI
  • San Francisco, California
    China Basin, UCSF
May 9, 2022

Metastatic Solid Tumor Trial ([18F]AlF-RESCA-IL2 PET scan)

Not yet recruiting
  • Metastatic Solid Tumor
  • [18F]AlF-RESCA-IL2 PET scan
  • (no location specified)
Jul 20, 2022

Glioma Trial in Oxford (Fluorodopa PET tracer)

Recruiting
  • Glioma
  • Fluorodopa PET tracer
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Hospitals NHS Foundation Trust
Jul 28, 2022

F18-MHF: Orthopedic Implants-Associated Infection Detection

Not yet recruiting
  • Knee Disease
  • Knee Infection
  • Atlanta, Georgia
    Emory University Hospital
May 25, 2023

Cancer Trial in Wuxi (18F-FAPI, 68Ga-FAPI)

Recruiting
  • Cancer
  • Wuxi, China
    Affiliated Hospital of Jiangnan University
Jan 19, 2023

Clinical Applicantion of Multi-Tracer PET/MR Imaging in

Recruiting
  • Alzheimer Disease
  • +3 more
  • PET/MR
  • Beijing, Beijing, China
    Xuanwu hospital
Oct 18, 2023

Coronary Artery Disease Trial in Saint Louis (Ga-68 Galmydar, 13N-ammonia)

Recruiting
  • Coronary Artery Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 20, 2022

Autoimmune Encephalomyelitis Trial in Shanghai (18F-DPA-714 PET)

Recruiting
  • Autoimmune Encephalomyelitis
  • 18F-DPA-714 PET
  • Shanghai, China
    Ruijin Hospital
Mar 15, 2022

Coronary Artery Disease (CAD) Trial in Beijing (XTR004)

Completed
  • Coronary Artery Disease (CAD)
  • Beijing, Beijing, China
  • +1 more
May 23, 2023

Positron-Emission Tomography, Metastatic Solid Tumors Trial in United States (8?Zr-Df-IAB22M2C)

Completed
  • Positron-Emission Tomography
  • Metastatic Solid Tumors
  • Birmingham, Alabama
  • +14 more
Nov 15, 2022

Cancer Trial in Stockholm (68Ga-NOTA-PEG2-RM26)

Recruiting
  • Cancer
  • Stockholm, Sweden
    Karolinska University Hospital
Nov 23, 2023

Solid Tumor, Lung Cancer Trial in Beijing (18F-WL12 PET or 68Ga-WL12 PET)

Recruiting
  • Solid Tumor
  • Lung Cancer
  • 18F-WL12 PET or 68Ga-WL12 PET
  • Beijing, China
    Shunlian Zhou
Jul 18, 2022

Newly Diagnosed or Recurrent Metastatic Melanoma Patients, Malignant Brain Tumors Trial in New York (PET scan with

Active, not recruiting
  • Newly Diagnosed or Recurrent Metastatic Melanoma Patients
  • Malignant Brain Tumors
  • PET scan with 124I-cRGDY-PEG-dots
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 13, 2022

Hepatocellular Carcinoma Trial (Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI
  • (no location specified)
Jan 8, 2023